Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus

被引:19
作者
Lamnissou, K
Ziorgiannis, P
Trygonis, S
Demetriou, K
Pierides, A
Koptides, M
Deltas, CC
机构
[1] Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus
[2] Univ Athens, Dept Biol, Div Genet, GR-15701 Athens, Greece
[3] G Gennimatas Hosp, Dept Nephrol, Athens, Greece
[4] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus
[5] Intercoll, Dept Biomed Sci, Nicosia, Cyprus
[6] Cyprus Inst Neurol & Genet, Dept Mol Genet C, Nicosia, Cyprus
来源
GENETIC TESTING | 2004年 / 8卷 / 03期
关键词
D O I
10.1089/gte.2004.8.319
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nitric oxide (NO) is thought to be an important factor in the deterioration of renal function. A variable-number tandem 27-bp repeat in intron 4 of the endothelial cell nitric oxide synthase (NOS3) gene has been found to be associated with the plasma levels of NO metabolites. Two alleles are of varied frequencies in different populations (a and b). The shorter allele a has been associated in Japanese populations with the progression of renal disease. Here we investigated this hypothesis by studying the putative role of this polymorphism in a Hellenic population of patients with end-stage renal disease (ESRD). We analyzed the genotypes of 361 ESRD patients and 295 healthy Hellens from Greece and Cyprus. The frequencies of NOS34bb, NOS34ab, and NOS34aa were 0.69, 0.27, and 0.03, respectively, in the control group and 0.71, 0.24, and 0.04 in the group of patients. The data in the two populations were analyzed by the chi-square and Fisher's exact tests. The frequencies of these three genotypes of NOS34 polymorphism in the Hellenic population of Greece and Cyprus are similar to those observed in other Caucasian populations. Moreover, our results from three patient groups, autosomal dominant polycystic kidney disease (ADPKD), diabetes mellitus (DM), and non-DM, showed that the frequencies of aa and ab genotypes in the patient populations were not significantly different from those observed in the control group. This work indicates that NOS34 polymorphism does not show any association with the development of ESRD in this studied European population. However, examination of the data regarding progression to ESRD within 5 years or after more than 5 years following clinical diagnosis of ADPKD provided evidence of statistical difference (p = 0.048, before Bonferroni correction), with faster progression in the group of ADPKD patients who carried allele a.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 22 条
  • [1] Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease
    Asakimori, Y
    Yorioka, N
    Yamamoto, I
    Okumoto, S
    Doi, S
    Hirai, T
    Taniguchi, Y
    [J]. NEPHRON, 2001, 89 (02): : 219 - 223
  • [2] CONTROL OF REGIONAL BLOOD-FLOW BY ENDOTHELIUM-DERIVED NITRIC-OXIDE
    GARDINER, SM
    COMPTON, AM
    BENNETT, T
    PALMER, RMJ
    MONCADA, S
    [J]. HYPERTENSION, 1990, 15 (05) : 486 - 492
  • [3] HYPERTENSION IN MICE LACKING THE GENE FOR ENDOTHELIAL NITRIC-OXIDE SYNTHASE
    HUANG, PL
    HUANG, ZH
    MASHIMO, H
    BLOCH, KD
    MOSKOWITZ, MA
    BEVAN, JA
    FISHMAN, MC
    [J]. NATURE, 1995, 377 (6546) : 239 - 242
  • [4] Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population
    Ichihara, S
    Yamada, Y
    Fujimura, T
    Nakashima, N
    Yokota, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01) : 83 - +
  • [5] MARSDEN PA, 1993, J BIOL CHEM, V268, P17478
  • [6] Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy
    Merta, M
    Reiterová, J
    Tesar, V
    Stekrová, J
    Viklicky, O
    [J]. RENAL FAILURE, 2002, 24 (05) : 585 - 593
  • [7] A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS
    MILLER, SA
    DYKES, DD
    POLESKY, HF
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (03) : 1215 - 1215
  • [8] CLONING AND STRUCTURAL CHARACTERIZATION OF THE HUMAN ENDOTHELIAL NITRIC-OXIDE-SYNTHASE GENE
    MIYAHARA, K
    KAWAMOTO, T
    SASE, K
    YUI, Y
    TODA, K
    YANG, LX
    HATTORI, R
    AOYAMA, T
    YAMAMOTO, Y
    DOI, Y
    OGOSHI, S
    HASHIMOTO, K
    KAWAI, C
    SASAYAMA, S
    SHIZUTA, Y
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 223 (03): : 719 - 726
  • [9] Morita T, 1999, CLIN NEPHROL, V52, P203
  • [10] GENE STRUCTURE, POLYMORPHISM AND MAPPING OF THE HUMAN ENDOTHELIAL NITRIC-OXIDE SYNTHASE GENE
    NADAUD, S
    BONNARDEAUX, A
    LATHROP, M
    SOUBRIER, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (03) : 1027 - 1033